Fundraising FoxLeaps by Bayer — 2022 Investments
9 investments dated 2022 · listed companies and verified rows first · show all
Dewpoint Therapeutics develops condensate-modulating drugs by using an integrated platform that maps, measures, and modulates biomolecular condensates to identify druggable targets and disease mechanisms.
AI & Machine LearningBiotechDeep TechBoston, US
Richard Young, Ph.D.(Director)inAnthony Hyman, Ph.D.(Director)Tony Hyman(Scientific Co-founder)Rick Young(Scientific Co-founder)Elisabeth Leiderman(Executive Officer)inIsaac Klein, M.D., Ph.D.(Executive Officer)
Co-investorsARCH Venture PartnersEcoR1 CapitalGeneral CatalystSamsara BioCapital6 Dimensions CapitalInnovation Endeavors+6 more
.png)
Ada offers intelligent health technology, including a medical library of doctor-created, research-based information about conditions and symptoms to help people make informed health decisions.
AI & Machine LearningDigital HealthHealthtech
Claire Novorol(Founder)Daniel Nathrath(Founder)Martin Hirsch(Founder)
Co-investorsRed River WestSamsung Catalyst FundUrania Ventures10x FoundersBertelsmann InvestmentsMutschler Ventures+1 more
Affini-T Therapeutics develops TCR-based immunotherapies aimed at treating solid tumors, using two complementary therapeutic modalities.
BiotechHealthtechLongevity
Co-investorsAgent CapitalJacket River Capital PartnersOlive Tree CapitalService Provider CapitalFred Hutchinson Cancer Research CenterHumboldt+1 more
Cellineobio develops cell engineering and bioprocess technology platforms.
AI & Machine LearningBiotechDeep TechMedical DevicesCambridge, US
Nabiha Saklayen, PhD(Co-Founder & CEO)inMarinna Madrid, PhD(Co-Founder & Chief Product Officer)inNabiha Saklayen(Founder)inMatthias Wagner(Founder)inMarinna Madrid(Founder)Stan Wang(Founder)
Co-investors8VCCota CapitalFelicis VenturesHAWKTAILKhosla VenturesThe Engine Ventures+1 more
Dewpoint Innovations develops functional nanostructured polymeric surfaces for atmospheric water capture, technology originating from PhD research at the University of Sydney.
CleantechClimate TechDeep TechNew Materials
Chiara Neto(Founder & Advisor (Chief Scientific Officer))inMing Chiu(Founder & CTO)in
Co-investorsImpact Ventures Management Pty LtdPacific Channel3E Bioventures CapitalARCH Venture PartnersEcoR1 CapitalGeneral Catalyst+3 more
Gandeeva Therapeutics uses AI, machine learning, and atomic-resolution cryo-EM imaging to map druggable protein interactions and design molecular glues that bind at specific protein interfaces.
AI & Machine LearningBiotechDeep TechDigital Health
Sriram Subramaniam(Founder)in
Co-investorsLux CapitalObvious VenturesAmgen VenturesAmplitude Venture Capital
Metagenomi is a genetic medicines company developing therapies based on gene editing technologies to treat patients with serious diseases.
BiotechDeep TechHealthtechMedical DevicesBerkeley, US
Brian Thomas(Founder)inBrian Thomas Jillian Banfield(Founder)Jill Banfield(Founder)Jian Irish(President and CEO)
BoardAndrew Farquharson(Director)inJak Knowles(Director)
Co-investorsCatalio Capital Management, LPRA CapitalSozo VenturesAgent CapitalFrazier Life SciencesHumboldt+5 more
NuCicer develops improved crop varieties through selective breeding, starting with high-protein chickpeas designed for better nutrition.
AgTechAI & Machine LearningFoodTechDavis, US
Kathryn Cook(Executive Officer, Director)inDouglas Cook(Executive Officer, Director)
BoardPaimun Amini(Director)inJerry Steiner(Director)inCarsten Boers(Director)in
Co-investorsBetter Ventures Central LlcBlue Horizon CorporationIllumina VenturesLever VCRhapsody Venture PartnersStray Dog Capital+1 more
.png)
AgTechEmeryville, US
Eric Davidson(Director)inTravis Bayer(Director)inPaul Beck(Executive Officer)inDave Vosburg(Executive Officer)Adam Litle(Executive Officer, Director)inDerek Norman(Director)in
Co-investorsCavallo VenturesCultivian Sandbox VenturesFall Line CapitalFootPrint CoalitionS2G InvestmentsNorthpond Ventures+2 more
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.